Methods of treating neurofibromatosis with perillyl alcohol
AssigneeNeOnc Technologies, Inc.
InventorThomas CHEN
Life of this patent
Estimating the term…
Abstract
The present methods treat neurofibromatosis by a administering to a subject perillyl alcohol or iso-perillyl alcohol. The present methods also treat neurofibromatosis by administering to a subject a carbamate of perillyl alcohol, or a carbamate of iso-perillyl alcohol. The perillyl alcohol carbamate may comprise perillyl alcohol conjugated with rolipram or temozolomide.
Claims21
(canceled)
A method of treating neurofibromatosis, comprising administering to a subject a therapeutically effective amount of a carbamate of perillyl alcohol, a carbamate of an iso-perillyl alcohol, or a combination thereof.
A method of inhibiting or decreasing Ras level and/or activity in a cell, comprising administering to the cell perillyl alcohol, an iso-perillyl alcohol, or a combination thereof.
(canceled)
A method of inhibiting or decreasing Ras level and/or activity in a subject, comprising administering to the subject an effective amount of perillyl alcohol, an iso-perillyl alcohol, or a combination thereof.
(canceled)
21-29. (canceled)
Dependencies are inferred from the claim text.